Radspherin

N/A

Report date: 2026/04/18 20:00:19

NME

Base Information

Drug NameRadspherin

Drug Alias Name224Ra-labeled CaCO3 microparticlesIntraperitoneal α-emitting Radionuclide Therapy224Radium-labeled microparticlesAlpha-emitting radionuclide therapyRa-224 based therapeutic +[8]

ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall moleculesRadiation-emitting products > Nuclides > Radium > 224Ra

Mechanisms of ActionIonising radiation emitters

TargetsNot applicable

Therapy Area/IndicationsColorectal NeoplasmsPeritoneal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSwedenNorway

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesOncoinvent As

China Registration ClassN/A

Develop Information

Active CompaniesOncoinvent As

Inactive CompaniesN/A

Active IndicationsColorectal NeoplasmsPeritoneal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A